OverviewSuggest Edit

Quest Diagnostics is a company providing diagnostic testing, information, and services. It offers diagnostic testing services through its network of laboratories and patient service centers, interpretive consultation through its medical and scientific staff, cancer diagnostics, and anatomic pathology services. The company serves patients, healthcare providers, pharmaceutical medical device companies, life insurance companies, and employers.

TypePublic
Founded1967
HQSecaucus, US
Websitequestdiagnostics.com
Employee Ratings3.4
Overall CultureC+

Latest Updates

Employees (est.) (Dec 2019)47,000(+3%)
Job Openings1,918
Revenue (FY, 2019)$7.7 B(+3%)
Share Price (Nov 2020)$121.4 (-1%)
Cybersecurity ratingBMore

Key People/Management at Quest Diagnostics

Tim Sharpe

Tim Sharpe

Vice President, Compliance
Shawn Bevec

Shawn Bevec

Vice President, Investor Relations
Stephen H. Rusckowski

Stephen H. Rusckowski

Chairman, CEO and President
Mark J. Guinan

Mark J. Guinan

Executive Vice President and Chief Financial Officer
Cecilia McKenney

Cecilia McKenney

Senior Vice President, Chief Human Resources Officer
Manuel O. Méndez

Manuel O. Méndez

Senior Vice President and Chief Commercial Officer
Show more

Quest Diagnostics Office Locations

Quest Diagnostics has offices in Secaucus, Santana De Parnaiba, Dublin and Ciudad de México
Secaucus, US (HQ)
500 Plaza Dr
Santana De Parnaiba, BR
1818 Estrada Tenente Marques, A06 & A07
Dublin, IE
Block 1, Unit 10, 9 Northwood Ave, Northside
Ciudad de México, MX
Frontera 4, Roma Nte., Cuauhtémoc
Ciudad de México, MX
World Trade Center 9th Floor, Office 19 Col. Napoles, Deleg. Benito Juarez
Show all (5)

Quest Diagnostics Financials and Metrics

Quest Diagnostics Revenue

Embed Graph
View revenue for all periods
Quest Diagnostics's revenue was reported to be $7.73 b in FY, 2019
USD

Revenue (Q3, 2020)

2.8b

Gross profit (Q3, 2020)

1.2b

Gross profit margin (Q3, 2020), %

43.3%

Net income (Q3, 2020)

591.0m

EBIT (Q3, 2020)

718.0m

Market capitalization (12-Nov-2020)

16.4b

Closing stock price (12-Nov-2020)

121.4

Cash (30-Sept-2020)

1.6b

EV

19.9b
Quest Diagnostics's current market capitalization is $16.4 b.
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

7.4b7.1b7.4b7.5b7.5b7.7b7.5b7.7b

Revenue growth, %

4%1%0%3%

Cost of goods sold

4.4b4.3b4.6b4.7b4.6b4.7b4.9b5.0b

Gross profit

3.0b2.8b2.8b2.8b2.9b3.0b2.6b2.7b
Quarterly
USDQ1, 2010Q2, 2010Q3, 2010Q4, 2010Q1, 2011Q2, 2011Q3, 2011Q4, 2011Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

1.8b1.9b1.9b7.4b1.8b1.9b1.9b7.5b1.9b1.9b1.8b1.8b1.8b1.7b1.9b1.9b1.8b1.9b1.9b1.9b1.9b1.9b1.9b1.9b1.9b1.9b3.8b1.9b1.9b2.0b2.0b1.8b1.8b2.8b

Cost of goods sold

1.1b1.1b1.1b4.3b1.1b1.1b1.1b4.4b1.1b1.1b1.1b1.1b1.1b1.1b1.2b1.2b1.2b1.2b1.2b1.1b1.2b1.2b1.2b1.2b1.2b1.2b2.5b1.2b1.2b1.3b1.3b1.3b1.2b1.6b

Gross profit

739.1m795.8m773.2m3.1b724.6m798.8m789.8m3.1b796.3m761.7m694.8m722.1m698.6m645.0m728.0m726.0m676.0m743.0m718.0m719.0m751.0m728.0m734.0m773.0m741.0m658.0m1.3b667.0m647.0m688.0m692.0m552.0m606.0m1.2b

Gross profit Margin, %

41%42%41%41%40%42%41%41%42%41%39%40%39%37%38%38%37%39%38%39%39%39%39%40%38%35%35%35%34%35%35%30%33%43%
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

295.6m187.0m192.0m133.0m359.0m137.0m135.0m1.2b

Accounts Receivable

867.0m926.0m924.0m1.0b1.1b

Prepaid Expenses

91.0m155.0m150.0m144.0m112.0m

Inventories

93.1m91.0m110.0m84.0m82.0m95.0m99.0m123.0m
Quarterly
USDQ1, 2010Q2, 2010Q3, 2010Q4, 2010Q1, 2011Q2, 2011Q3, 2011Q4, 2011Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

463.2m447.9m369.3m449.3m994.2m184.2m110.8m164.9m173.7m191.8m133.6m148.3m158.3m144.0m144.0m170.0m974.0m150.0m123.0m128.0m283.0m406.0m367.0m314.0m350.0m124.0m132.0m263.0m464.0m273.0m434.0m342.0m988.0m1.6b

Accounts Receivable

865.2m869.6m884.1m845.3m940.4m929.4m936.3m906.5m941.5m930.7m930.0m946.8m1.1b1.1b1.1b1.1b972.0m1.1b1.4b

Prepaid Expenses

313.8m299.4m310.8m365.4m364.4m349.2m329.9m108.4m86.2m97.8m126.4m148.0m137.0m100.0m116.0m120.0m112.0m117.0m

Inventories

79.5m78.4m73.2m76.6m71.7m88.0m85.0m89.1m90.1m94.5m89.8m89.4m85.2m99.0m109.0m111.0m106.0m109.0m86.0m82.0m80.0m82.0m77.0m83.0m100.0m94.0m91.0m95.0m98.0m105.0m112.0m126.0m154.0m205.0m
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

555.7m883.0m592.0m753.0m696.0m824.0m788.0m906.0m

Depreciation and Amortization

286.6m304.0m249.0m270.0m309.0m329.0m

Accounts Payable

(13.2m)(21.0m)68.0m(24.0m)56.0m(8.0m)(19.0m)73.0m

Cash From Operating Activities

1.2b652.0m938.0m821.0m1.1b1.2b1.2b1.2b
Quarterly
USDQ1, 2010Q2, 2010Q3, 2010Q4, 2010Q1, 2011Q2, 2011Q3, 2011Q4, 2011Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Net Income

171.2m357.1m555.1m720.9m(53.9m)109.3m281.1m470.6m336.8m499.9m135.8m301.2m732.1m111.0m253.0m392.0m70.0m199.0m553.0m114.0m324.0m529.0m175.0m382.0m557.0m189.0m422.0m649.0m164.0m415.0m641.0m106.0m299.0m890.0m

Depreciation and Amortization

63.3m126.3m190.4m254.0m63.4m136.1m209.4m281.1m144.0m215.3m70.2m142.0m211.0m75.0m156.0m235.0m78.0m153.0m230.0m62.0m123.0m186.0m62.0m128.0m197.0m74.0m151.0m228.0m108.0m165.0m247.0m85.0m174.0m263.0m

Accounts Payable

(81.9m)(84.6m)(26.6m)18.2m(47.1m)(74.5m)(84.4m)(17.6m)(87.7m)(56.1m)(77.1m)(68.2m)(76.8m)(86.0m)(39.0m)20.0m(120.0m)(49.0m)(41.0m)(77.0m)23.0m43.0m(95.0m)(93.0m)(3.0m)(68.0m)(64.0m)51.0m32.0m27.0m80.0m(47.0m)42.0m514.0m

Cash From Operating Activities

239.2m448.4m778.5m1.1b160.6m220.1m557.7m895.5m412.1m806.8m47.2m255.3m441.6m84.0m364.0m635.0m52.0m327.0m539.0m143.0m464.0m765.0m196.0m490.0m852.0m180.0m503.0m905.0m275.0m596.0m895.0m247.0m602.0m1.5b
USDQ1, 2010

Financial Leverage

2.2 x
Show all financial metrics

Quest Diagnostics Operating Metrics

FY, 2016

Accounts

250 k

Patents Issued

700

Patents Pending

570

Patient Service Centers

2.20 k
Show all operating metrics

Quest Diagnostics Acquisitions / Subsidiaries

Company NameDateDeal Size
California Laboratory AssociatesOctober 30, 2017
Cleveland HeartLabOctober 18, 2017
Cape Cod Healthcare - BusinessJune 28, 2017
ClearPoint DiagnosticJune 12, 2017
Med fusionJune 12, 2017
PeaceHealth LaboratoriesFebruary 15, 2017

Quest Diagnostics Revenue Breakdown

Embed Graph

Quest Diagnostics revenue breakdown by business segment: 95.6% from Diagnostic Information Services and 4.4% from Other

Quest Diagnostics Cybersecurity Score

Cybersecurity ratingPremium dataset

B

80/100

SecurityScorecard logo

Quest Diagnostics Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

Quest Diagnostics Online and Social Media Presence

Embed Graph

Quest Diagnostics Company Culture

  • Overall Culture

    C+

    65/100

  • CEO Rating

    C+

    67/100

  • Compensation

    C+

    64/100

  • Diversity

    B

    71/100

Learn more on Comparably

Quest Diagnostics News and Updates

Quest Diagnostics and Catapult Health Provide Virtual Preventive Care Services for Employers During COVID-19 Pandemic and Beyond

SECAUCUS, N.J., Oct. 27, 2020 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Catapult Health, the leading national provider of employer-sponsored Preventive Checkups, have formed a collaboration designed to help...

Global Autoimmune Diseases Diagnostics Market Report 2020-2025 with Profiles of Abbott Laboratories, Siemens AG, Beckman Coulter Inc. and Quest Diagnostics

Dublin, Oct. 26, 2020 (GLOBE NEWSWIRE) -- The "Global Autoimmune Diseases Diagnostics Market 2020-2025 by Product, Test Type, Disease, End-user, Geography and Impact of Covid-19 with Ansoff's Analysis" report has been added to ResearchAndMarkets.com's offering. The Global Autoimmune Disease Diag…

Quest Diagnostics shares jump 3.8% premarket as earnings beat on demand for COVID-19 tests

Quest Diagnostics Inc. shares jumped 3.8% in premarket trade Thursday, after the company beat third-quarter earnings estimates and raised guidance, buoyed by demand for COVID-19 testing. Secaucus, N.J.-based Quest said it had net income of $568 million, or $4.14 a share, in the quarter, up from $21…

Fentanyl and Heroin Misuse Skyrockets During COVID-19 Pandemic, Finds Quest Diagnostics Health Trends Study

SECAUCUS, N.J., Oct. 15, 2020 /PRNewswire/ -- A new Quest Diagnostics Health Trends study indicates that misuse of fentanyl, heroin and nonprescribed opioids are on the rise, potentially due to the COVID-19 pandemic's impact on healthcare access and support for individuals most at-risk...

National Business Group on Health Honors Quest Diagnostics with Best Employers: Excellence in Health & Well-Being Award

SECAUCUS, N.J., Oct. 15, 2020 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received the 2020 Best Employers: Excellence in Health & Well-Being award, presented by the National Business Group on...

Quest Diagnostics Receives 2020 C. Everett Koop National Health Award for Outstanding Employee Health Program

SECAUCUS, N.J., Oct. 12, 2020 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received the prestigious C. Everett Koop National Health Award for 2020. Named for C. Everett Koop, the 13th Surgeon...
Show more

Quest Diagnostics Blogs

Quest Diagnostics Frequently Asked Questions

  • When was Quest Diagnostics founded?

    Quest Diagnostics was founded in 1967.

  • Who are Quest Diagnostics key executives?

    Quest Diagnostics's key executives are Tim Sharpe, Shawn Bevec and Stephen H. Rusckowski.

  • How many employees does Quest Diagnostics have?

    Quest Diagnostics has 47,000 employees.

  • What is Quest Diagnostics revenue?

    Latest Quest Diagnostics annual revenue is $7.7 b.

  • What is Quest Diagnostics revenue per employee?

    Latest Quest Diagnostics revenue per employee is $164.4 k.

  • Who are Quest Diagnostics competitors?

    Competitors of Quest Diagnostics include Invitae, Sonic Healthcare and Abbott.

  • Where is Quest Diagnostics headquarters?

    Quest Diagnostics headquarters is located at 500 Plaza Dr, Secaucus.

  • Where are Quest Diagnostics offices?

    Quest Diagnostics has offices in Secaucus, Santana De Parnaiba, Dublin and Ciudad de México.

  • How many offices does Quest Diagnostics have?

    Quest Diagnostics has 5 offices.